Citations

Showing 10 of 108135 citations.

Generation of Factor VIII :C By Isolated Pig and Rat Livers
Owen, C. A. , Bowie, E. J. Walter, Fass, David N.

Mayo Clinic

Thrombosis and Haemostasis | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1665804 Get It

When isolated neonatal pig livers were perfused with blood from pigs with von Willebrand’s disease, no factor VIII coagulant activity (VIII:C) emerged in the perfusate. When purified porcine Willebrand factor, lacking VIII:C, was added to the perfusate it rapidly diminished, presumably being taken up by the liver. Concurrently VIII:C rose steadily in the blood during the 5 hours of perfusion. Similarly, isolated adult rat livers released no VIII:C when they were perfused with rat erythrocytes suspended in Tyrode’s solution containing 6% bovine serum albumin. VIII:C did emerge if cryoprecipitate from aged rat plasma were added. The neo-VIII:C was rapidly inactivated by plasma from a patient with classic hemophilia who had developed an antibody to VIII:C Addition of cycloheximide to the rat before extirpation of the liver, as well as to the perfusate, prevented the emergence of VIII:C. We suspect that VIII:C is derived from the liver but only when Willebrand factor is present.
Investigation of the Catalytic Properties of the Dysthrombin, Thrombin Quick
Henriksen, R.A., Owen, Whyte G., Nesheim, Michael E., Mann, K G, Henriksen, R.A.

Mayo Clinic

Thrombosis and Haemostasis | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1665671 Get It

Thrombin Quick (TQ) may be isolated following treatment of Prothrombin Quick [Owen, et al, Mayo Clinic Proceedings, 53: 29-33, (1978)] with Taipan venom, phospholipid and ca2+. The clotting activity of TQ with fibrinogen is 1/200 that of nornar thrombin (T). The activation of Factors V and VIII, and the aggregation of platelets by TQ occurs with an effectiveness of about 1/50 that of thrombin. when incubated with antithrombin III, both T ad TQ fom inhibitor complexes as determined by dodecylsulfate gel electropheresis. Titration of T and TQ with the fluorescent inhibitor dansylarginine-4-ethylpiperidine amide indicates an equivalent number of active sites based on protein absorption at 280 nm. However, the two enzymes may be distinquished by the decreased fluorescence enhancement observed with TQ relative to T, indicating an increased polarity in the inhibitor binding site of TQ. With the substrate benzoylarginine ethylester, TQ has a Km = 4.5 × 10-5M and kcat= 6.93 compared to Km = 4.0 × 10-5M and kcat= 17.7 for T. This indicates that the defect in TQ esterase activity is in the catalytic mechanism itself and not in substrate binding. The rate of inhibition of TQ by diisopropylphosphofluoridate is decreased. Decreased acylation and deacylation rates for TQ relative to T are observed for hydrolysis of the active site titrant 4-methykl-umbelliferyl-p-guanidinobenzoate
Indium-111-Tropolone: A New High-Affinity Tracer For Platelet Labeling, Preparation And Evaluation
Dewanjee, Mrinal K., Rao, Shyam A., Didisheim, Paul

Mayo Clinic

Thrombosis and Haemostasis | May 13, 2019 | Volume: 46 | Issue: No issue available | Pages: No page available

10.1055/s-0038-1653283 Get It

Platelets have been labeled with a new, neutral, lipidsoluble metal-complex of Indium-111-tropolone (In-TPL). Unlike oxine, tropolone is soluble in isotonic saline. Oil/saline partition of In-111-oxine and In-TPL are 0.5 and 23.7 respectively. Platelet labeling with In-TPL was performed in both ACD-plasma and ACD-saline media within two hours' time. Increasing concentration of tropolone, citrate ion, and plasma proteins decreases plateletlabeling efficiency. Effects of pH, temperature, platelet concentration, and calcium ion concentration on platelet labeling were studied. In optimum platelet-labeling conditions, canine, rabbit, porcine, and human platelets have been labeled with a consistent labeling efficiency of 80-90%. The optimum labeling conditions are In-TPL in ACD- saline and ACD-plasma at tropolone concentration of 5 and 10 μg/ml respectively and 30 minutes’ incubation of platelets with the tracer at room temperature. A kit formulation for convenient routine preparation of In-111-labeled platelets has been developed. The function of the In-TPL- labeled platelets has been studied by their aggregability with adenosine diphosphate. The capacity of In-111-labeled platelets to aggregate in vitro does not correlate well with their ability to circulate in vivo. No adverse effect of In-TPL on platelets has been observed by studies of biodistribution, recovery, and platelet survival in dogs. Comparable mean platelet survival times of four repeated studies in five dogs were obtained in both ACD-saline and ACD-plasma. These results indicate that Indium-111 platelets labeled by tropolone carrier may be preferable to oxine carrier for studies of platelet survival, imaging sites of endothelial damage, and thrombus formation.
COMBINATION ENDOSCOPIC THERAPY USING ENDOSPONGE AND OVER-THE-SCOPE-CLIP FOR THE THERAPY OF COMPLEX GASTROINTESTINAL LEAKS AND DEHISCENCES
Martinez-Alcala, A, D'Assunção, MA, Kroener, PT, Mönkemüller, Klaus, Martinez-Alcala, A, Gutierrez, JP

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681745 Get It

THE UAB RAPTOR METHOD FACILITATES DIRECT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION TUBE PLACEMENT (WITH VIDEO)
Martinez-Alcala, A, Kroener, PT, Peter, Solomon Danjuma, Diaz-Tobar, Claudia, Mönkemüller, Klaus, Martinez-Alcala, A, Peter, S

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681420 Get It

"POSTERIOR-LIKE" ANTERIOR POEM
Mavrogenis, G, Tsevgas, I, Karamanolis, George , Zachariadis, D, Mavrogenis, G, Bazerbachi, Fateh , Tsevgas, Ioannis, Karamanolis, G, Zachariadis, Dimitrios

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681372 Get It

SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION (STER) FOR OBSTRUCTIVE DUODENAL LIPOMA
Mavrogenis, Georgios , Tsevgas, Ioannis, Zachariadis, Dimitrios, Bazerbachi, Fateh

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681247 Get It

CAPSULE RETENTION IN CROHN DISEASE: A META-ANALYSIS
Pasha, SF , Wolf, Douglas C. , Buras, MR, Albert, JG, Cohen, SA, D’Haens, Geert , Eliakim, Rami, Rubin, DT, Leighton, JA, Pennazio, Marco , Rondonotti, Emanuele , Cotter, José , Rubin, DT

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681198 Get It

Catechol O‐Methyltransferase Pharmacogenomics: Challenges and Opportunities
Ho, Ming‐Fen , Weinshilboum, Richard M. , Weinshilboum, Richard M. , Ho, Ming-Fen

Mayo Clinic

Clinical Pharmacology & Therapeutics | May 13, 2019 | Volume: 106 | Issue: 2 | Pages: 281-283

10.1002/cpt.1452 | PMID 31081936 Get It

Glial cells as therapeutic targets in progressive multiple sclerosis
Wilbanks, Brandon , Maher, L. James , Rodriguez, Moses , III, Louis James Maher , Rodriguez, Moses , Wilbanks, Brandon A

Mayo Clinic

Expert Review of Neurotherapeutics | May 13, 2019 | Volume: 19 | Issue: 6 | Pages: 481-494

10.1080/14737175.2019.1614443 | PMID 31081705 Get It